These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7706132)

  • 1. Novel antibiotics, amythiamicins. IV. A mutation in the elongation factor Tu gene in a resistant mutant of B. subtilis.
    Shimanaka K; Iinuma H; Hamada M; Ikeno S; Tsuchiya KS; Arita M; Hori M
    J Antibiot (Tokyo); 1995 Feb; 48(2):182-4. PubMed ID: 7706132
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of bacterial protein synthesis by elongation-factor-Tu-binding antibiotics MDL 62,879 and efrotomycin.
    Landini P; Bandera M; Goldstein BP; Ripamonti F; Soffientini A; Islam K; Denaro M
    Biochem J; 1992 May; 283 ( Pt 3)(Pt 3):649-52. PubMed ID: 1590753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GE2270A-resistant mutations in elongation factor Tu allow productive aminoacyl-tRNA binding to EF-Tu.GTP.GE2270A complexes.
    Zuurmond AM; Martien de Graaf J; Olsthoorn-Tieleman LN; van Duyl BY; Mörhle VG; Jurnak F; Mesters JR; Hilgenfeld R; Kraal B
    J Mol Biol; 2000 Dec; 304(5):995-1005. PubMed ID: 11124042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An elongation factor Tu (EF-Tu) resistant to the EF-Tu inhibitor GE2270 in the producing organism Planobispora rosea.
    Sosio M; Amati G; Cappellano C; Sarubbi E; Monti F; Donadio S
    Mol Microbiol; 1996 Oct; 22(1):43-51. PubMed ID: 8899707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of an EF-Tu complex with a thiazolyl peptide antibiotic determined at 2.35 A resolution: atomic basis for GE2270A inhibition of EF-Tu.
    Heffron SE; Jurnak F
    Biochemistry; 2000 Jan; 39(1):37-45. PubMed ID: 10625477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of elongation factor Tu (EF-Tu) from different bacterial species to the antibiotics efrotomycin, pulvomycin and MDL 62879.
    Landini P; Bandera M; Soffientini A; Goldstein BP
    J Gen Microbiol; 1993 Apr; 139(4):769-74. PubMed ID: 8515234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substitution of Arg230 and Arg233 in Escherichia coli elongation factor Tu strongly enhances its pulvomycin resistance.
    Boon K; Krab I; Parmeggiani A; Bosch L; Kraal B
    Eur J Biochem; 1995 Feb; 227(3):816-22. PubMed ID: 7867642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic GE37468 A: a new inhibitor of bacterial protein synthesis. I. Isolation and characterization.
    Stella S; Montanini N; Le Monnier F; Ferrari P; Colombo L; Marinelli F; Landini P; Ciciliato I; Goldstein BP; Selva E
    J Antibiot (Tokyo); 1995 Aug; 48(8):780-6. PubMed ID: 7592021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elongation factor Tu1 of the antibiotic GE2270A producer Planobispora rosea has an unexpected resistance profile against EF-Tu targeted antibiotics.
    Möhrle VG; Tieleman LN; Kraal B
    Biochem Biophys Res Commun; 1997 Jan; 230(2):320-6. PubMed ID: 9016775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial activities of chemically modified thiazolyl peptide antibiotic MDL 62,879 (GE2270A).
    Lociuro S; Tavecchia P; Marzorati E; Landini P; Goldstein BP; Denaro M; Ciabatti R
    J Antibiot (Tokyo); 1997 Apr; 50(4):344-9. PubMed ID: 9186562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amythiamicin D and related thiopeptides as inhibitors of the bacterial elongation factor EF-Tu: modification of the amino acid at carbon atom C2 of ring C dramatically influences activity.
    Gross S; Nguyen F; Bierschenk M; Sohmen D; Menzel T; Antes I; Wilson DN; Bach T
    ChemMedChem; 2013 Dec; 8(12):1954-62. PubMed ID: 24106106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elongation factor Tu3 (EF-Tu3) from the kirromycin producer Streptomyces ramocissimus Is resistant to three classes of EF-Tu-specific inhibitors.
    Olsthoorn-Tieleman LN; Palstra RJ; van Wezel GP; Bibb MJ; Pleij CW
    J Bacteriol; 2007 May; 189(9):3581-90. PubMed ID: 17337575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations to kirromycin resistance occur in the interface of domains I and III of EF-Tu.GTP.
    Abdulkarim F; Liljas L; Hughes D
    FEBS Lett; 1994 Sep; 352(2):118-22. PubMed ID: 7925958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two highly similar multidrug transporters of Bacillus subtilis whose expression is differentially regulated.
    Ahmed M; Lyass L; Markham PN; Taylor SS; Vázquez-Laslop N; Neyfakh AA
    J Bacteriol; 1995 Jul; 177(14):3904-10. PubMed ID: 7608059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory mechanisms of antibiotics targeting elongation factor Tu.
    Hogg T; Mesters JR; Hilgenfeld R
    Curr Protein Pept Sci; 2002 Feb; 3(1):121-31. PubMed ID: 12370016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aeruginazole A, a novel thiazole-containing cyclopeptide from the cyanobacterium Microcystis sp.
    Raveh A; Carmeli S
    Org Lett; 2010 Aug; 12(15):3536-9. PubMed ID: 20614868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of the action of pulvomycin and GE2270 A on elongation factor Tu.
    Parmeggiani A; Krab IM; Okamura S; Nielsen RC; Nyborg J; Nissen P
    Biochemistry; 2006 Jun; 45(22):6846-57. PubMed ID: 16734421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribosomally synthesized thiopeptide antibiotics targeting elongation factor Tu.
    Morris RP; Leeds JA; Naegeli HU; Oberer L; Memmert K; Weber E; LaMarche MJ; Parker CN; Burrer N; Esterow S; Hein AE; Schmitt EK; Krastel P
    J Am Chem Soc; 2009 Apr; 131(16):5946-55. PubMed ID: 19338336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant ribosomes can generate dominant kirromycin resistance.
    Tubulekas I; Buckingham RH; Hughes D
    J Bacteriol; 1991 Jun; 173(12):3635-43. PubMed ID: 2050625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and expression of elongation factor Tu from Bacillus stearothermophilus.
    Krásný L; Mesters JR; Tieleman LN; Kraal B; Fucík V; Hilgenfeld R; Jonák J
    J Mol Biol; 1998 Oct; 283(2):371-81. PubMed ID: 9769211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.